KalVista Pharmaceuticals Surges Following Acquisition Announcement by Chiesi Group
KalVista Pharmaceuticals (NASDAQ:KALV) surged 38.62% on April 29, 2026, following an announcement that Chiesi Group will acquire the company for $27 per share in cash. The stock's sharp rise reflects investor optimism about the acquisition, though risks related to deal closure and regulatory approvals remain. The biotechnology sector saw mixed performance, with Prothena (PRTA) declining.
Topics: acquisition Chiesi Group KalVista Pharmaceuticals pharmaceuticals stock market